Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Hughes Financial Services »

Fennec Pharmaceuticals shares owned by Hughes Financial Services

Quarter-by-quarter ownership of Fennec Pharmaceuticals (FENC) shares owned by Hughes Financial Services from 13F filings

Historical chart of Hughes Financial Services investment in Fennec Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fennec Pharmaceuticals held by Hughes Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download consolidated filings csv

Download as Excel

Download consolidated filings xlsx

Quarterly reported holdings in Fennec Pharmaceuticals by Hughes Financial Services

Quarter filed	Position value	Share count	Share price at filing
2025-09-30	$828	108	7.68
2025-06-30	$880	108	8.16
2025-03-31	$597	108	5.53

More positions owned by Hughes Financial Services

State Street Spdr Portfolio S&p 1500 Composite Stock Market Etf Etf (SPTM)

Jpmorgan Core Plus Bond Etf Etf (JCPB)

Jpmorgan International Research Enhanced Equity Etf Etf (JIRE)

Ishares Msci Emerging Markets Ex China Etf Etf (EMXC)

Jpmorgan U.s. Tech Leaders Etf Etf (JTEK)

Ishares Core Dividend Growth Etf Etf (DGRO)

Ishares Msci Usa Quality Factor Etf Etf (QUAL)

Jpmorgan International Bond Opportunities Etf Of Benef Interest Etf (JPIB)

State Street Spdr Portfolio Tips Etf Etf (SPIP)

Ishares 1-3 Year Treasury Bond Etf Etf (SHY)

Dimensional U.s. Equity Market Etf Etf (DFUS)

Ishares 10-20 Year Treasury Bond Etf Etf (TLH)

Jpmorgan Hedged Equity Laddered Overlay Etf Etf (HELO)

State Street Spdr Msci Usa Strategicfactors Etf Etf (QUS)

Vanguard Ftse All-world Ex-us Index Fund Etf (VEU)

View all positions for Hughes Financial Services

Top funds holding Fennec Pharmaceuticals

Southpoint Capital Advisors

Solas Capital Management

Rosalind Advisors

AIGH Capital Management

State Street Corporation

Tang Capital Management

Geode Capital Management

Harbert Fund Advisors

Jeffrey L. Gendell

Lion Point Capital

Citadel Advisors

View all funds holding Fennec Pharmaceuticals

© 2025 stockzoa - Track 13F-HR Filings for Hedge Funds and Value Investors.

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z